10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 107 filers reported holding 10X GENOMICS INC in Q1 2020. The put-call ratio across all filers is 0.47 and the average weighting 2.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,066,619 | -34.4% | 753,130 | -11.2% | 0.68% | -20.3% |
| Q2 2023 | $47,342,276 | -0.1% | 847,820 | -0.2% | 0.86% | +29.3% |
| Q1 2023 | $47,379,339 | +32.3% | 849,244 | -13.6% | 0.66% | +37.1% |
| Q4 2022 | $35,813,847 | +25.1% | 982,817 | -2.3% | 0.48% | +15.6% |
| Q3 2022 | $28,637,000 | +469.9% | 1,005,542 | +2395.1% | 0.42% | +403.6% |
| Q3 2020 | $5,025,000 | -29.7% | 40,300 | -49.6% | 0.08% | -37.6% |
| Q2 2020 | $7,145,000 | -18.1% | 80,000 | -42.9% | 0.13% | -37.3% |
| Q1 2020 | $8,725,000 | – | 140,000 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,753,528 | $133,391,000 | 100.00% |
| Foresite Capital Management I, LLC | 750,000 | $57,053,000 | 99.71% |
| 12 West Capital Management LP | 2,518,500 | $191,582,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 1,336,253 | $101,649,000 | 9.59% |
| Blue Water Life Science Advisors, LP | 211,917 | $16,121,000 | 7.65% |
| Decheng Capital Management III (Cayman), LLC | 303,984 | $23,124,000 | 7.09% |
| FINANCIAL CONSULATE, INC | 154,942 | $11,786,000 | 4.53% |
| Evolutionary Tree Capital Management, LLC | 54,128 | $4,118,000 | 2.86% |
| HARVARD MANAGEMENT CO INC | 186,143 | $14,160,000 | 1.43% |
| Brown Capital Management | 1,663,469 | $126,540,000 | 1.26% |